Victoria Appatova named CLADEA Fellow

National award recognizes professor's contribution to developmental education

Victoria Appatova - UC Clermont Faculty & Staff

Victoria Appatova

University of Cincinnati Clermont College Professor of English Victoria Appatova has been elected as a Council of Learning Assistance and Developmental Education Associations (CLADEA) Fellow. The award recognizes her significant achievement in the field of post-secondary learning assistance and developmental education.

The CLADEA Fellows Program honors the excellence of top practitioners, policymakers, researchers, teachers and administrators in the field. Despite having around 100,000 educators in the discipline, only 69 individuals, including Appatova, have received this esteemed accolade to date. 

Appatova boasts more than 30 years of experience and has held influential roles in various organizations, making her a standout candidate for the highest honor in the United States for professionals in learning assistance, tutoring and developmental education. The induction ceremony is scheduled for March 18 at the ACTP Annual Conference in Charlotte, North Carolina.

About UC Clermont

UC Clermont College is located in the center of Clermont County on 91 beautifully wooded acres in Batavia Township. The college is an accredited, open-access institution offering more than 60 programs and degrees. UC Clermont is part of the nationally recognized University of Cincinnati. For more information, call 513-556-5400 or visit www.ucclermont.edu.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.